Recent advances, novel targets and treatments for cholelithiasis; a narrative review. E S, Srikanth MS, Shreyas A, Desai S, Mehdi S, Gangadharappa HV, Suman, Krishna KL. Eur J Pharmacol. 2021 Oct 05;908:174376. doi: 10.1016/j.ejphar.2021.174376. Epub 2021 Jul 22. PMID: 34303667
Therapy of gallstone disease: What it was, what it is, what it will be. Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. World J Gastrointest Pharmacol Ther. 2012 Apr 06;3(2):7-20. doi: 10.4292/wjgpt.v3.i2.7. PMID: 22577615
Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models. Cui Y, Li Z, Zhao E, Zhang J, Cui N. EXCLI J. 2012 Aug 31;11:593-603. eCollection 2012. PMID: 27847447
New insights into the role of . Wang HH, Li T, Portincasa P, Ford DA, Neuschwander-Tetri BA, Tso P, Wang DQ. Liver Res. 2017 Jun;1(1):42-53. doi: 10.1016/j.livres.2017.05.005. Epub 2017 Jun 03. PMID: 34367715
Gallstones. Hoogerwerf WA, Soloway RD. Curr Opin Gastroenterol. 1999 Sep;15(5):442-7. doi: 10.1097/00001574-199909000-00012. PMID: 17023987